Delivery Order SPE2DB22D2006-SPE2DB25FV7JP

Award Date 1/2/25
Potential Completion Date 1/3/25
Potential Value $7.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,583.74 firm-fixed-price delivery order is for the supply of 4561971208 - LIDOCAINE 5% PATCH 30S. It has an ultimate completion date of August 29, 2023. The award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,557.52 firm-fixed-price delivery order contract is for the supply of LIDOCAINE 5% PATCH 30S, a medical commodity used for pain management. The contract has a period of performance through January 6, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $3,822.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of October 29, 2024 and is a firm-fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued at $999,999,999...
This federal contract award, with ID SPE2DB22D3004|SPE2DB25FNX53, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The award is for the delivery of 4566779352 - LIDOCAINE 5% PATCH 30S, with a ceiling value of $2,366.23 and a completion date of December 23, 2024. The contract type is a Delivery Order with Firm Fixed Pricing. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $3,321.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, which are medical products used for pain management. The award is a delivery order placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award is a delivery order with a ceiling value of $1,166.52, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566623596 - LIDOCAINE 5% PATCH 30S, with a firm fixed-price pricing type and a completion date of December 6, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a...
This federal contract award, with the ID SPE2DB22D2211|SPE2DB24FMYU7, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4563905592 - LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract is a firm fixed price delivery order with a ceiling value of $2,205.48 and a performance period through March 11, 2024. Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a for-profit...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The $4,006.77 firm-fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a medical product used to treat pain. The contract has an ultimate completion date of September 11, 2024. Amerisourcebergen has been awarded this contract as a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $1,932.75, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4562627791 LIDOCAINE 5% PATCH 30S, a pharmaceutical product. The contract has an ultimate completion date of October 30, 2023 and is a Firm Fixed Price Delivery Order. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
This federal contract award with ID SPE2DB24D1104|SPE2DB25FXWC9 was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,594.59 fixed-price delivery order is for the supply of LIDOCAINE 5% PATCH 30S, a medical product, with a period of performance through January 6, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV7JP
    Delivery Order

This federal contract award, with an ID of SPE2DB22D2006|SPE2DB25FV7JP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of LIDOCAINE 5% PATCH 30S, a medical product, with a total ceiling value of $7,426.02. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of January 3, 2025.

The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and there are no major subcontractors mentioned in the information provided. As a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/3/25, 10:02 AM